400 liter reactor in the pilot plant at the site in Redmond, USA. Chemical reactions are done successfully under CGMP for substance supply and scale up for phase I/II and preclinical phase. Photo: Saltigo GmbH

Separation for closed handling of pharmaceutical intermediates and APIs at the Saltigo site in Redmond, USA. Photo: Saltigo GmbH

The hastelloy filterdryer in an API plant at the Saltigo site in Leverkusen, Germany, allows filtration and drying up to 1 ton per batch of pharmaceutical intermediate and API. Several FDA audits have been passed successfully. Photo: Saltigo GmbH

5 m3 hastelloy reactor for hydrogenations at high pressure and temperatures (200 °C/200 bar). The reactions are possible under CGMP for pharmaceutical intermediates. The destillation of products is done in the same plant. Other unit operations are available in the other Saltigo plants at the Leverkusen site in Germany. Photo: Saltigo GmbH

Highly efficient distillation plant with up to 120 theoretical plates allows the separation of complex mixtures with small boiling point differences. Operation temperatures range from 50-230 °C (120-450 F) and pressures from 5 to 200 mbar (0.1-3 psi). Charging and filling of products via iso-tank container or drums. Advantageous is the close interconnection via piping or container transport to the integrated system of Saltigo/LANXESS plants in Leverkusen, Germany. Campaign sizes range from 10 to 5000 tons per year. Photo: Saltigo GmbH

The German consumer organization "Stiftung Warentest" has given high marks to insect repellents containing Saltidin. The World Health Organization (WHO) even recommends this product from LANXESS' subsidiary Saltigo GmbH as the active ingredient of choice in preventing malaria. Photo: Saltigo GmbH